Pharmaceutical Executive-03-01-2012

Pharmaceutical Executive

With growth as its guiding light, Novartis has big plans for the emerging markets. Pharm Exec sits down with CEO Joe Jimenez to understand what it will take the company to best the competition.

Issue PDF
Pharmaceutical Executive

March 01, 2012

Leading in Emerging Markets

Pharmaceutical Executive
Regulatory

March 01, 2012

How can we better balance addressing medical needs with ensuring that new drugs are safe and effective? Ron Cohen reports.

European Report
Pharmaceutical Executive

March 01, 2012

After his predecessor and countryman left the EMA in disgrace, Guido Rasi jumps in as executive director-with great challenges ahead.

Pharmaceutical Executive

Our annual press audit finds that the big news in 2011 for pharma was ... no news.

Pharmaceutical Executive
From the Editor

March 01, 2012

Pharm Exec's latest EAB meeting offered a frank exchange on this magazine's digital future.

Pharmaceutical Executive

Making real connections that resonate with audiences in a digital world is a fine art, especially in the heavily regulated world of Big Pharma

Pharmaceutical Executive
Marketing

March 01, 2012

Pharmaceutical trade dres is an effective marketing tool that helps boost product recognition for consumers. It's worth protecting.

Pharmaceutical Executive
Column

March 01, 2012

FDA and industry are pushing user fees, while they struggle with curbs on communications.

Pharmaceutical Executive
Back Page

March 01, 2012

In the rush to collect as much patient data as possible, are we sacrificing quality for quantity? Ben Comer reports.